CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in CRDF — Cardiff Oncology, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in CRDF
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$266,826
-$263,294 QoQ
Shares Held
164,708
-12.7% QoQ
Ownership
0.212%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRDF Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in CRDF
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $266,826 | 164,708 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $530,120 | 188,655 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $389,988 | 189,315 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $596,342 | 189,315 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $533,718 | 169,974 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $441,221 | 101,664 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $323,852 | 121,293 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $241,513 | 108,790 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $87,570 | 16,399 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $24,270 | 16,399 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $22,794 | 16,399 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $24,106 | 16,399 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $27,058 | 16,399 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $22,958 | 16,399 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $25,254 | 16,399 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $36,077 | 16,399 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $255,794 | 103,143 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $587,555 | 97,763 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $651,101 | 97,763 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $569,353 | 85,617 | Shares | Sole | 2021-08-16 | |
| 2020-09-30 | $165,114 | 11,636 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||